The Emerging Role of CTLA-4 as an Immune Attenuator
- 1 October 1997
- Vol. 7 (4), 445-450
- https://doi.org/10.1016/s1074-7613(00)80366-0
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- B7-1 and B7-2 Have Overlapping, Critical Roles in Immunoglobulin Class Switching and Germinal Center FormationImmunity, 1997
- CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast KineticsThe Journal of Experimental Medicine, 1997
- The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes RegistryHuman Molecular Genetics, 1996
- Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR EngagementImmunity, 1996
- Enhancement of Antitumor Immunity by CTLA-4 BlockadeScience, 1996
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 1995
- CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian populationJournal of Clinical Endocrinology & Metabolism, 1995
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994
- Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.The Journal of Experimental Medicine, 1992
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991